Analyze Diet
Virology2003; 313(2); 588-603; doi: 10.1016/s0042-6822(03)00351-9

Enhancement of equine infectious anemia virus virulence by identification and removal of suboptimal nucleotides.

Abstract: Pathogenicity was reportedly restored to an avirulent molecular clone of equine infectious anemia virus (EIAV) by substitution of 3' sequences from the pathogenic variant strain (EIAV(PV)). However, the incidence of disease in horses/ponies was found to be significantly lower (P = 0.016) with the chimeric clone (EIAV(UK)) than with EIAV(PV). This was attributable to 3' rather than 5' regions of the proviral genome, where EIAV(UK) differs from the consensus EIAV(PV) sequence by having a 68-bp duplication in the 3' LTR and arginine (R(103)) rather than tryptophan (W(103)) at position 103 in the second exon of rev. In EIAV(UK) recipients the duplication was rapidly eliminated and R(103) replaced by W(103) in the viral population. Furthermore, removal of the 3' variant sequences from EIAV(UK) (EIAV(UK3)) resulted in an equivalent (P = 0.013) disease potential in Equus caballus to EIAV(PV). The 68-bp duplication and/or R(103) may limit peak viral RNA accumulation during acute infection.
Publication Date: 2003-09-05 PubMed ID: 12954224DOI: 10.1016/s0042-6822(03)00351-9Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Research Support
  • U.S. Gov't
  • P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research paper discusses how the virulence, or disease-causing potential, of the equine infectious anemia virus (EIAV) was increased by identifying and eliminating suboptimal nucleotides from the virus’s genetic material.

About the EIAV and Its Variants

The equine infectious anemia virus (EIAV) is a lentivirus that leads to equine infectious anemia, a serious and often fatal disease among horses. This paper studies two forms of the EIAV: an avirulent, or non-disease-causing form called EIAV(UK), and a pathogenic or disease-causing one referred to as EIAV(PV).

  • The researchers initially created a hybrid of these two forms by replacing some genetic sequences from EIAV(UK) with sequences from EIAV(PV).
  • Despite these changes, horses injected with the chimeric clone still developed the disease less frequently than those with EIAV(PV).

The Role of Suboptimal Nucleotides

Suboptimal nucleotides refer to DNA sequences that aren’t exactly “ideal” or fully effective. In this case, such suboptimal sequences in EIAV(UK) resulted in lower virulence. Two discrepancies were specifically identified between the EIAV(UK) and EIAV(PV):

  • A 68-base pair duplication in the 3′ Long Terminal Repeat (LTR) region of the proviral genome (the DNA form of the virus after it has integrated into the host cell’s genome).
  • In the second exon of the viral “rev” gene, there was a substitution of arginine (R) instead of tryptophan (W) at the 103rd position.

Enhancing Virulency

The researchers were able to enhance the EIAV(UK) virus’s virulence by eliminating these suboptimal nucleotides:

  • The 68 base pair duplication was naturally eliminated rapidly in horses who received the EIAV(UK).
  • The 103rd position arginine was naturally replaced by tryptophan within the viral population in those horses.
  • Manually removing these variant sequences from EIAV(UK) resulted in a disease potential that was equivalent to EIAV(PV).

The data suggest that these suboptimal sequences – the 68 base pair duplication and arginine in place of tryptophan, limit the virus’s ability to generate high amounts of viral RNA during the acute infection phase thus reducing its virulence.

Cite This Article

APA
Cook RF, Cook SJ, Berger SL, Leroux C, Ghabrial NN, Gantz M, Bolin PS, Mousel MR, Montelaro RC, Issel CJ. (2003). Enhancement of equine infectious anemia virus virulence by identification and removal of suboptimal nucleotides. Virology, 313(2), 588-603. https://doi.org/10.1016/s0042-6822(03)00351-9

Publication

ISSN: 0042-6822
NlmUniqueID: 0110674
Country: United States
Language: English
Volume: 313
Issue: 2
Pages: 588-603

Researcher Affiliations

Cook, R Frank
  • Department of Veterinary Science, Gluck Equine Research Center, University of Kentucky, Lexington, KY 40546, USA. rfcook1@uky.edu
Cook, Sheila J
    Berger, Sandra L
      Leroux, Caroline
        Ghabrial, Nadia N
          Gantz, Marie
            Bolin, Pamela S
              Mousel, Michelle R
                Montelaro, Ronald C
                  Issel, Charles J

                    MeSH Terms

                    • Amino Acid Sequence
                    • Amino Acid Substitution
                    • Animals
                    • Arginine / genetics
                    • Cells, Cultured
                    • Equine Infectious Anemia / virology
                    • Gene Products, gag / genetics
                    • Gene Products, pol / genetics
                    • Horses
                    • Infectious Anemia Virus, Equine / genetics
                    • Infectious Anemia Virus, Equine / pathogenicity
                    • Molecular Sequence Data
                    • Open Reading Frames
                    • Sequence Alignment
                    • Terminal Repeat Sequences
                    • Tryptophan / genetics
                    • Viral Load
                    • Virulence
                    • Virus Replication

                    Grant Funding

                    • R01CA49296 / NCI NIH HHS

                    Citations

                    This article has been cited 11 times.
                    1. Câmara RJF, Bueno BL, Resende CF, Balasuriya UBR, Sakamoto SM, Reis JKPD. Viral Diseases that Affect Donkeys and Mules.. Animals (Basel) 2020 Nov 25;10(12).
                      doi: 10.3390/ani10122203pubmed: 33255568google scholar: lookup
                    2. Lohmann KL, James CR, Higgins SN, Howden KJ, Epp T. Disease investigations for equine infectious anemia in Canada (2009-2012) - Retrospective evaluation and risk factor analysis.. Can Vet J 2019 Nov;60(11):1199-1206.
                      pubmed: 31692681
                    3. Higgins SN, Howden KJ, James CR, Epp T, Lohmann KL. A retrospective study of owner-requested testing as surveillance for equine infectious anemia in Canada (2009-2012).. Can Vet J 2017 Dec;58(12):1294-1300.
                      pubmed: 29203939
                    4. Han X, Zhang P, Yu W, Xiang W, Li X. Amino acid mutations in the env gp90 protein that modify N-linked glycosylation of the Chinese EIAV vaccine strain enhance resistance to neutralizing antibodies.. Virus Genes 2016 Dec;52(6):814-822.
                      doi: 10.1007/s11262-016-1382-2pubmed: 27572122google scholar: lookup
                    5. Liu Q, Ma J, Wang XF, Xiao F, Li LJ, Zhang JE, Lin YZ, Du C, He XJ, Wang X, Zhou JH. Infection with equine infectious anemia virus vaccine strain EIAVDLV121 causes no visible histopathological lesions in target organs in association with restricted viral replication and unique cytokine response.. Vet Immunol Immunopathol 2016 Feb;170:30-40.
                      doi: 10.1016/j.vetimm.2016.01.006pubmed: 26832985google scholar: lookup
                    6. Craigo JK, Ezzelarab C, Cook SJ, Liu C, Horohov D, Issel CJ, Montelaro RC. Protective efficacy of centralized and polyvalent envelope immunogens in an attenuated equine lentivirus vaccine.. PLoS Pathog 2015 Jan;11(1):e1004610.
                      doi: 10.1371/journal.ppat.1004610pubmed: 25569288google scholar: lookup
                    7. Ma J, Wang SS, Lin YZ, Liu HF, Liu Q, Wei HM, Wang XF, Wang YH, Du C, Kong XG, Zhou JH, Wang X. Infection of equine monocyte-derived macrophages with an attenuated equine infectious anemia virus (EIAV) strain induces a strong resistance to the infection by a virulent EIAV strain.. Vet Res 2014 Aug 9;45(1):82.
                      doi: 10.1186/s13567-014-0082-ypubmed: 25106750google scholar: lookup
                    8. Du J, Wang X, Ma J, Wang J, Qin Y, Zhu C, Liu F, Shao Y, Zhou J, Qiao W, Liu X. Structural and biochemical insights into the V/I505T mutation found in the EIAV gp45 vaccine strain.. Retrovirology 2014 Mar 21;11:26.
                      doi: 10.1186/1742-4690-11-26pubmed: 24656154google scholar: lookup
                    9. Cappelli K, Capomaccio S, Cook FR, Felicetti M, Marenzoni ML, Coppola G, Verini-Supplizi A, Coletti M, Passamonti F. Molecular detection, epidemiology, and genetic characterization of novel European field isolates of equine infectious anemia virus.. J Clin Microbiol 2011 Jan;49(1):27-33.
                      doi: 10.1128/JCM.01311-10pubmed: 21084503google scholar: lookup
                    10. Craigo JK, Barnes S, Zhang B, Cook SJ, Howe L, Issel CJ, Montelaro RC. An EIAV field isolate reveals much higher levels of subtype variability than currently reported for the equine lentivirus family.. Retrovirology 2009 Oct 20;6:95.
                      doi: 10.1186/1742-4690-6-95pubmed: 19843328google scholar: lookup
                    11. Craigo JK, Zhang B, Barnes S, Tagmyer TL, Cook SJ, Issel CJ, Montelaro RC. Envelope variation as a primary determinant of lentiviral vaccine efficacy.. Proc Natl Acad Sci U S A 2007 Sep 18;104(38):15105-10.
                      doi: 10.1073/pnas.0706449104pubmed: 17846425google scholar: lookup